Trends in Women With an HIV Diagnosis at Delivery Hospitalization in the United States, 2006-2014

Overview

Journal Public Health Rep

Publisher Sage Publications

Specialty Public Health

Date 2020 Jul 11

PMID 32649273

Citations 2

Authors

Maria Vyshnya Aslam

Kwame Owusu-Edusei

Steven R Nesheim

Kristen Mahle Gray

Margaret A Lampe

Patricia Marie Dietz

Affiliations

Soon will be listed here.

Abstract

Objectives: The risk of mother-to-child HIV transmission can be reduced to ≤0.5% if the mother's HIV status is known before delivery. This study describes 2006-2014 trends in diagnosed HIV infection documented on delivery discharge records and associated sociodemographic characteristics among women who gave birth in US hospitals.

Methods: We analyzed data from the 2006-2014 National Inpatient Sample and identified delivery discharges and women with diagnosed HIV infection by using codes. We used a generalized linear model with log link and binomial distribution to assess trends and the association of sociodemographic characteristics with an HIV diagnosis on delivery discharge records.

Results: During 2006-2014, an HIV diagnosis was documented on approximately 3900-4400 delivery discharge records annually. The probability of having an HIV diagnosis on delivery discharge records decreased 3% per year (adjusted relative risk [aRR] = 0.97; 95% CI, 0.94-0.99), with significant declines identified among white women aged 25-34 (aRR = 0.93; 95% CI, 0.88-0.97) or those using Medicaid (aRR = 0.93; 95% CI, 0.90-0.97); among black women aged 25-34 (aRR = 0.95; 95% CI, 0.92-0.99); and among privately insured women who were black (aRR = 0.96; 95% CI, 0.92-0.99), Hispanic (aRR = 0.92; 95% CI, 0.86-0.98), or aged 25-34 (aRR = 0.96; 95% CI, 0.92-0.99). The probability of having an HIV diagnosis on delivery discharge records was greater for women who were black (aRR = 8.45; 95% CI, 7.56-9.44) or Hispanic (aRR = 1.56; 95% CI, 1.33-1.83) than white; for women aged 25-34 (aRR = 2.33; 95% CI, 2.12-2.55) or aged ≥35 (aRR = 3.04; 95% CI, 2.79-3.31) than for women aged 13-24; and for Medicaid recipients (aRR = 2.70; 95% CI, 2.45-2.98) or the uninsured (aRR = 1.87; 95% CI, 1.60-2.19) than for privately insured patients.

Conclusion: During 2006-2014, the probability of having an HIV diagnosis declined among select sociodemographic groups of women delivering neonates. High-impact prevention efforts tailored to women remaining at higher risk for HIV infection can reduce the risk of mother-to-child HIV transmission.

Citing Articles

Rheumatoid arthritis and cardiovascular complications during delivery: a United States inpatient analysis.

Zahid S, Mohamed M, Rajendran A, Minhas A, Khan M, Nazir N Eur Heart J. 2024; 45(17):1524-1536.

PMID: 38427130 PMC: 11075931. DOI: 10.1093/eurheartj/ehae108.

Achieving Elimination of Perinatal HIV in the United States.

Lampe M, Nesheim S, Oladapo K, Ewing A, Wiener J, Kourtis A Pediatrics. 2023; 151(5).

PMID: 37070379 PMC: 10387171. DOI: 10.1542/peds.2022-059604.

References

Ewing A, Datwani H, Flowers L, Ellington S, Jamieson D, Kourtis A . Trends in hospitalizations of pregnant HIV-infected women in the United States: 2004 through 2011. Am J Obstet Gynecol. 2016; 215(4):499.e1-8. DOI: 10.1016/j.ajog.2016.05.048. View

Wortley P, Lindegren M, Fleming P . Successful implementation of perinatal HIV prevention guidelines. A multistate surveillance evaluation. MMWR Recomm Rep. 2004; 50(RR-6):17-28. View

. Recommendations of the U.S. Public Health Service Task Force on the use of zidovudine to reduce perinatal transmission of human immunodeficiency virus. MMWR Recomm Rep. 1994; 43(RR-11):1-20. View

Whitmore S, Zhang X, Taylor A, Blair J . Estimated number of infants born to HIV-infected women in the United States and five dependent areas, 2006. J Acquir Immune Defic Syndr. 2011; 57(3):218-22. DOI: 10.1097/QAI.0b013e3182167dec. View

Hornbrook M, Whitlock E, Berg C, Callaghan W, Bachman D, Gold R . Development of an algorithm to identify pregnancy episodes in an integrated health care delivery system. Health Serv Res. 2007; 42(2):908-27. PMC: 1955367. DOI: 10.1111/j.1475-6773.2006.00635.x. View

Heslin K, Owens P, Karaca Z, Barrett M, Moore B, Elixhauser A . Trends in Opioid-related Inpatient Stays Shifted After the US Transitioned to ICD-10-CM Diagnosis Coding in 2015. Med Care. 2017; 55(11):918-923. DOI: 10.1097/MLR.0000000000000805. View

Arab K, Spence A, Czuzoj-Shulman N, Abenhaim H . Pregnancy outcomes in HIV-positive women: a retrospective cohort study. Arch Gynecol Obstet. 2017; 295(3):599-606. DOI: 10.1007/s00404-016-4271-y. View

Hamilton B, Martin J, Osterman M, Curtin S, Matthews T . Births: Final Data for 2014. Natl Vital Stat Rep. 2016; 64(12):1-64. View

Heron M, Hoyert D, Murphy S, Xu J, Kochanek K, Tejada-Vera B . Deaths: final data for 2006. Natl Vital Stat Rep. 2009; 57(14):1-134. View

10.

Taylor A, Nesheim S, Zhang X, Song R, FitzHarris L, Lampe M . Estimated Perinatal HIV Infection Among Infants Born in the United States, 2002-2013. JAMA Pediatr. 2017; 171(5):435-442. PMC: 5470358. DOI: 10.1001/jamapediatrics.2016.5053. View

11.

Nesheim S, Taylor A, Lampe M, Kilmarx P, Harris L, Whitmore S . A framework for elimination of perinatal transmission of HIV in the United States. Pediatrics. 2012; 130(4):738-44. DOI: 10.1542/peds.2012-0194. View

12.

Whitmore S, Taylor A, Espinoza L, Shouse R, Lampe M, Nesheim S . Correlates of mother-to-child transmission of HIV in the United States and Puerto Rico. Pediatrics. 2011; 129(1):e74-81. DOI: 10.1542/peds.2010-3691. View

13.

MacDorman M, Gregory E . Fetal and Perinatal Mortality: United States, 2013. Natl Vital Stat Rep. 2015; 64(8):1-24. View

14.

. ACOG committee opinion scheduled Cesarean delivery and the prevention of vertical transmission of HIV infection. Number 234, May 2000 (replaces number 219, August 1999). Int J Gynaecol Obstet. 2001; 73(3):279-81. DOI: 10.1016/s0020-7292(01)00412-x. View

15.

. Medicare program; changes to the hospital inpatient prospective payment systems and fiscal year 2008 rates. Fed Regist. 2007; 72(162):47129-8175. View

16.

Trepka M, Mukherjee S, Beck-Sague C, Maddox L, Fennie K, Sheehan D . Missed Opportunities for Preventing Perinatal Transmission of Human Immunodeficiency Virus, Florida, 2007-2014. South Med J. 2017; 110(2):116-128. PMC: 5308514. DOI: 10.14423/SMJ.0000000000000609. View

17.

Peters H, Francis K, Sconza R, Horn A, Peckham C, Tookey P . UK Mother-to-Child HIV Transmission Rates Continue to Decline: 2012-2014. Clin Infect Dis. 2017; 64(4):527-528. DOI: 10.1093/cid/ciw791. View

18.

. Recommendations for assisting in the prevention of perinatal transmission of human T-lymphotropic virus type III/lymphadenopathy-associated virus and acquired immunodeficiency syndrome. MMWR Morb Mortal Wkly Rep. 1985; 34(48):721-6, 731-2. View

19.

Haddad L, Wall K, Mehta C, Golub E, Rahangdale L, Kempf M . Trends of and factors associated with live-birth and abortion rates among HIV-positive and HIV-negative women. Am J Obstet Gynecol. 2016; 216(1):71.e1-71.e16. PMC: 5182149. DOI: 10.1016/j.ajog.2016.09.079. View

20.

. HIV-2 Infection Surveillance--United States, 1987-2009. MMWR Morb Mortal Wkly Rep. 2011; 60(29):985-8. View